↓ Skip to main content

Cyclin E2 Overexpression Is Associated with Endocrine Resistance but not Insensitivity to CDK2 Inhibition in Human Breast Cancer Cells

Overview of attention for article published in Molecular Cancer Therapeutics, July 2012
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (77th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (54th percentile)

Mentioned by

patent
50 patents

Readers on

mendeley
106 Mendeley
citeulike
1 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Article details
Title
Cyclin E2 Overexpression Is Associated with Endocrine Resistance but not Insensitivity to CDK2 Inhibition in Human Breast Cancer Cells
Published in
Molecular Cancer Therapeutics, July 2012
DOI 10.1158/1535-7163.mct-11-0963
Pubmed ID
Authors

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
Activity
Login to access the full charts related to this output.
Mendeley demographics

Mendeley demographics

The data shown below were compiled from readership statistics for 106 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Login to view Mendeley reader trends over time.

Geographical breakdown

Geographical breakdown
Country Count As %
Portugal 1 <1%
Malaysia 1 <1%
United Kingdom 1 <1%
Unknown 103 97%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Researcher 24 23%
Student > Ph. D. Student 15 14%
Student > Master 12 11%
Student > Doctoral Student 6 6%
Other 5 5%
Other 16 15%
Unknown 28 26%
Readers by discipline
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 21 20%
Medicine and Dentistry 17 16%
Agricultural and Biological Sciences 15 14%
Chemistry 8 8%
Pharmacology, Toxicology and Pharmaceutical Science 5 5%
Other 11 10%
Unknown 29 27%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 July 2026.
All research outputs
#4,896,388
of 23,543,207 outputs
Outputs from Molecular Cancer Therapeutics
#921
of 3,917 outputs
Outputs of similar age
#33,236
of 165,409 outputs
Outputs of similar age from Molecular Cancer Therapeutics
#13
of 42 outputs
Altmetric has tracked 23,543,207 research outputs across all sources so far. Compared to these this one has done well and is in the 76th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,917 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.5. This one has gotten more attention than average, scoring higher than 67% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 165,409 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 77% of its contemporaries.
We're also able to compare this research output to 42 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 54% of its contemporaries.